Valeant had been hoping to command an estimated $2 billion market. Valeant Pharmaceuticals VRX -11.82% International was sued on behalf of former investors in Sprout Pharmaceuticals, which it bought last year for $1 billion, over its alleged failure to
See Original Article

Critical holiday quarter forecast disappointed investors. Fitbit has long been the most successful maker of high-tech wearables but one of the least successful initial public offerings among high-tech stocks.
See Original Article

As Bloomberg View's Elaine Ou pointed out this week, some of the newest cryptocurrencies such as Zcash and Monero have gained popularity fast
See Original Article

Payroll expert Jim Paille shares updates about minimum wage changes for the new year.
See Original Article

Accounting Representative in with Florida State University. Apply Today.
See Original Article